Medpace Holdings, Inc. cotiza a 609.89 USD y tiene una capitalización bursátil de $17.0B. En los últimos 12 meses ha facturado $2.8B con un margen de flujo de caja libre del 26.9%. Cotiza a 24.1 veces su flujo de caja libre (P/FCF) y a un PER de 34.6. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides…
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $4.25 | $4.28 | $4.67 |
| Estimado | $4.46 | $4.00 | $3.96 | $4.23 |
| Sorpresa | — | +6.3% | +8.1% | +10.4% |
| Métrica | MEDP | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | 21.1% | -38.6% | +59.8% |
| Net Margin | 17.8% | -33.6% | +51.4% |
| FCF Margin | 26.9% | -13.9% | +40.8% |
| ROE | 98.3% | -40.4% | +138.7% |
| ROA | 22.8% | -32.0% | +54.8% |
| Current Ratio | 0.74 | 2.84 | -2.10 |
| Debt / Equity | — | 0.28 | — |